賓達汀凍晶注射劑

국가: 대만

언어: 중국어

출처: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

유효 성분:

BENDAMUSTINE HYDROCHLORIDE

제공처:

健喬信元醫藥生技股份有限公司 新竹縣湖口鄉工業一路6號 (43199950)

ATC 코드:

L01AA09

약제 형태:

凍晶注射劑

구성:

BENDAMUSTINE HYDROCHLORIDE (1004002510) MG; TERTIARY-BUTYL ALCOHOL (9600208100) MG

패키지 단위:

盒裝

수업:

製　劑

처방전 유형:

限由醫師使用

Manufactured by:

INTAS PHARMACEUTICALS LIMITED PLOT NO. 5 TO 14, PHARMEZ, NEAR VILLAGE MATODA, TAL: SANAND, CITY: MATODA, DIST: AHMEDABAD, GUJARAT STATE, INDIA IN

치료 영역:

bendamustine

치료 징후:

1.Binet分類stage B及C之慢性淋巴球白血病(chronic lymphocytic leukemia,CLL)。2.曾接受至少一種化療之和緩性非何杰金氏淋巴瘤，六個月內曾以rituximab治療失敗之單一治療。3.Bendamustine合併Rituximab適用於先前未曾接受治療的CD20陽性、第 III / IV 期和緩性非何杰金氏淋巴癌(non-hodgkin lymphoma, NHL)。Bendamustine合併Rituximab適用於先前未曾接受治療且不適合自體幹細胞移植的第 III / IV 期被套細胞淋巴癌(mantle cell lymphoma, MCL)。

제품 요약:

有效日期: 2028/08/09; 英文品名: Bendine Powder for Solution for Infusion

승인 날짜:

2023-08-09